Nevada · 2025 Regular Session · Bill
AB 555: Establishes provisions relating to the coverage of prescription insulin drugs under certain policies of health insurance. (BDR 57-1167)
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
AB 555 is a bill introduced in the Nevada House on May 8, 2025. According to its official title, it concerns: Establishes provisions relating to the coverage of prescription insulin drugs under certain policies of health insurance. (BDR 57-1167). Primary sponsor: Steve Yeager (Democratic). Most recent recorded action (June 6, 2025): Chapter 265.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Steve Yeager | Primary sponsor | Democratic | House | 9 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Chapter 265.
- Approved by the Governor.
- Enrolled and delivered to Governor.
- In Assembly. To enrollment.
- Read third time. Passed. Title approved. (Yeas: 18, Nays: 2, Excused: 1.) To Assembly.
- From committee: Do pass. Placed on Second Reading File. Read second time.
- Read third time. Passed. Title approved. (Yeas: 42, Nays: None.) To Senate. In Senate. Read first time. Referred to Committee on Commerce and Labor. To committee.
- From committee: Do pass. Placed on Second Reading File. Read second time.
- From printer. To committee.
- Read first time. Referred to Committee on Commerce and Labor. To printer.